CCO Slideset

New Options for Renal Cell Carcinoma

Source: New Options for Renal Cell Carcinoma

New Options for Renal Cell Carcinoma

CME Program Director: Nicholas J. Vogelzang, MD

Faculty:

Daniel J. George, MD
Eric Jonasch, MD
Jihad H. Kaouk, MD

CME CREDIT INFORMATION

Release Date: 04/23/07

Expiration Date: 04/22/08

Physicians: maximum of 1.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

List current and emerging surgical options for surgical and cryosurgical treatment of localized and small renal cell tumors
Recount data that support systemic therapy for metastatic renal cell carcinoma, including first- and second-line treatment approaches
Describe emerging data from investigations that focus on adjuvant and neoadjuvant treatment of renal cell carcinoma

Topics covered include:

Introduction

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.